Building the Investment Case for Action against Antimicrobial Resistance (AMR)

Events Since 2001

Building the Investment Case for Action against Antimicrobial Resistance (AMR)

02/29/2024
Online Event

Hosted by the Quadripartite-powered One Health Nexus Community of Practice on the Return on Investment (ROI) for One Health and One Health Investment Planning. AMR has the potential to become an international trade and economic issue linked to health security, food safety and sustainable development. Estimates of economic losses caused by increasing AMR range from 1.1 - 3.8 percent of annual gross domestic product (GDP) by 2050. Yet there is currently inadequate financial support for the sustainable implementation of national action plans on AMR. This webinar discussed a business-as-usual scenario to estimate the current and projected cost of AMR (using SPHeP analysis), provided a better understand key AMR interventions and their costs, benefits, and effectiveness, and shared updates on progress being made on the global AMR investment case to estimate the Return on Investment of the AMR response. (Recording availability unknown) https://tinyurl.com/3ucpdszf

© 2024 One Health Commission. All rights reserved.